Alyftrek 20 mg

Alyftrek 20 mg tablets contain tezacaftor, a medication used to treat certain conditions related to cystic fibrosis. This oral medication is designed to improve lung function and overall health in patients with specific genetic mutations.

Alyftrek 20 mg tablets are primarily used in the management of cystic fibrosis. Tezacaftor works by enhancing the function of a protein involved in chloride transport, which is often defective in individuals with cystic fibrosis. This can help improve lung function and reduce the frequency of pulmonary exacerbations. The medication is typically prescribed as part of a combination therapy to address the underlying causes of the disease.

Common effects of Alyftrek 20 mg tablets may include headaches, fatigue, and gastrointestinal issues such as nausea or diarrhea. Some individuals may also experience dizziness or changes in liver function. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Alyftrek 20 mg tablets should be handled with care, especially for individuals with liver conditions or a history of allergic reactions to similar medications. Regular monitoring of liver function is recommended. The medication should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Alyftrek 20 mg tablets may interact with certain medications, including strong CYP3A inducers or inhibitors, which can affect the metabolism of tezacaftor. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.